Sustained efficacy of etanercept (Enbrel®) in ankylosing spondylitis up to 18 months.

被引：0
|
作者：
Davis, JC
van der Heijde, DM
Braun, J
Dougados, M
Cush, JJ
Clegg, DO
Kivitz, AJ
Inman, RD
Whitmore, J
Tsuji, W
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Univ Paris 05, Paris, France
[4] Rheumazentrum, Herne, Germany
[5] Presbyterian Med Ctr, Dallas, TX USA
[6] Univ Utah, Med Ctr, Salt Lake City, UT USA
[7] Altoona Ctr Clin Res, Duncansville, PA USA
[8] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S611 / S611
页数：1
相关论文
共 50 条
  • [1] Sustained efficacy of etanercept in ankylosing spondylitis for up to 2 years
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, J
    Clegg, DO
    Inman, RD
    Kivitz, A
    Zhou, L
    Tsuji, W
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 336 - 336
  • [2] The efficacy of etanercept in ankylosing spondylitis
    Christopher T. Ritchlin
    [J]. Current Rheumatology Reports, 2004, 6 (2) : 95 - 96
  • [3] The efficacy of etanercept in ankylosing spondylitis
    Christopher T. Ritchlin
    [J]. Current Rheumatology Reports, 2004, 6 (2) : 95 - 95
  • [4] Efficacy of etanercept in ankylosing spondylitis hip lesions
    Wang, Dongxue
    Ma, Li
    Wu, Donghai
    [J]. JOINT BONE SPINE, 2011, 78 (05) : 531 - 532
  • [5] Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
    Davis, J. C.
    van der Heijde, D.
    Braun, D.
    Dougados, M.
    Clegg, D. O.
    Kivits, A.
    Fleischmann, R.
    Inmann, R.
    Ni, L.
    Lin, S.
    Tsuji, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 393 - 394
  • [6] Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
    Davis, J. C., Jr.
    van der Heijde, D. M.
    Braun, J.
    Dougados, M.
    Clegg, D. O.
    Kivitz, A. J.
    Fleischmann, R. M.
    Inman, R. D.
    Ni, L.
    Lin, S-L
    Tsuji, W. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 346 - 352
  • [7] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [8] Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
    Davis, JC
    van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, J
    Clegg, D
    Inman, RD
    Kivitz, A
    Zhou, L
    Solinger, A
    Tsuji, W
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) : 1557 - 1562
  • [9] One-year efficacy of etanercept in ankylosing spondylitis
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, JJ
    Clegg, DO
    Kivitz, AJ
    Inman, RD
    Solinger, A
    Whitmore, J
    Tsuji, W
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 390 - 390
  • [10] Baseline factors influential on ASAS 20 response in ankylosing spondylitis patients treated with etanercept (ENBREL®)
    Davis, JC
    van der Heijde, DM
    Dougados, M
    Braun, J
    Cush, JJ
    Clegg, DO
    Inman, RD
    Devries, T
    Tsuji, WH
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S440 - S440
12345